Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Gains from Investment Securities (2018 - 2026)

Viemed Healthcare filings provide 8 years of Gains from Investment Securities readings, the most recent being -$1.7 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to -$1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50000.0, a 65.99% decrease, with the full-year FY2025 number at $50000.0, down 65.99% from a year prior.
  • Gains from Investment Securities hit -$1.7 million in Q4 2025 for Viemed Healthcare, down from $101000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $3.8 million in Q2 2024 to a low of -$3.7 million in Q3 2024.
  • Median Gains from Investment Securities over the past 5 years was $196000.0 (2023), compared with a mean of $388823.5.
  • Biggest five-year swings in Gains from Investment Securities: surged 31112.5% in 2022 and later crashed 540.38% in 2023.
  • Viemed Healthcare's Gains from Investment Securities stood at $8000.0 in 2021, then surged by 31112.5% to $2.5 million in 2022, then skyrocketed by 41.53% to $3.5 million in 2023, then plummeted by 204.53% to -$3.7 million in 2024, then skyrocketed by 54.47% to -$1.7 million in 2025.
  • The last three reported values for Gains from Investment Securities were -$1.7 million (Q4 2025), $101000.0 (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.